The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl

Human Molecular Genetics

Volumn 19, Issue 12, 2010, Pages 2516-2523

  Takahashi, Meiko ^a   Saenko, Vladimir A ^b   Rogounovitch, Tatiana I ^b   Kawaguchi, Takahisa ^a   Drozd, Valentina M ^c   Takigawa Imamura, Hisako ^a   Akulevich, Natallia M ^b   Ratanajaraya, Chanavee ^a   Mitsutake, Norisato ^b   Takamura, Noboru ^b   Danilova, Larisa I ^c   Lushchik, Maxim L ^c   Demidchik, Yuri E ^d   Heath, Simon ^e   Yamada, Ryo ^a   Lathrop, Mark ^e,f   Matsuda, Fumihiko ^a   Yamashita, Shunichi ^b  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c Department of Thyroid Disease Research ^*  (Belarus)

^d BELARUSIAN MEDICAL ACADEMY OF POSTGRADUATE EDUCATION   (Belarus)

^e CENTRE NATIONAL DE GÉNOTYPAGE   (France)

^f FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXE1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CHERNOBYL ACCIDENT; CHILD; CHROMOSOME 9Q; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION EXPOSURE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID PAPILLARY CARCINOMA;

ADULT; CARCINOMA, PAPILLARY; CHERNOBYL NUCLEAR ACCIDENT; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC LOCI; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NEOPLASMS, RADIATION-INDUCED; THYROID NEOPLASMS; YOUNG ADULT;

EID: 77955301455     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddq123     Document Type: Article

References (30)

1. Kazakov, V.S., Demidchik, E.P. and Astakhova, L.N. (1992) Thyroid cancer after Chernobyl. Nature, 359, 21.
2. Bennett, B., Repacholi, M. and Carr, Z. (2006) Report of the UN Chernobyl Forum Expert Group 'Health', WHO Press, Geneva.
3. Cardis, E., Kesminiene, A., Ivanov, V., Malakhova, I., Shibata, Y., Khrouch, V., Drozdovitch, V., Maceika, E., Zvonova, I., Vlassov, O. et al. (2005) Risk of thyroid cancer after exposure to 131I in childhood. J. Natl Cancer Inst., 97, 724-732.
4. Tronko, M.D., Howe, G.R., Bogdanova, T.I., Bouville, A.C., Epstein, O.V., Brill, A.B., Likhtarev, I.A., Fink, D.J., Markov, V.V., Greenebaum, E. et al. (2006) A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening. J. Natl Cancer Inst., 98, 897-903.
5. Williams, D. (2002) Cancer after nuclear fallout: lessons from the Chernobyl accident. Nat. Rev. Cancer, 2, 543-549.
6. Tronko, M.D., Brenner, A.V., Olijnyk, V.A., Robbins, J., Epstein, O.V., McConnell, R.J., Bogdanova, T.I., Fink, D.J., Likhtarev, I.A., Lubin, J.H. et al. (2006) Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J. Clin. Endocrinol. Metab., 91, 4344-4351.
7. Ron, E., Lubin, J.H., Shore, R.E., Mabuchi, K., Modan, B., Pottern, L.M., Schneider, A.B., Tucker, M.A. and Boice, J.D. Jr (1995) Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat. Res., 141, 259-277.
8. Pacini, F., Vorontsova, T., Demidchik, E.P., Molinaro, E., Agate, L., Romei, C., Shavrova, E., Cherstvoy, E.D., Ivashkevitch, Y., Kuchinskaya, E. et al. (1997) Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J. Clin. Endocrinol. Metab., 82, 3563-3569.
9. Jacob, P., Bogdanova, T.I., Buglova, E., Chepurniy, M., Demidchik, Y., Gavrilin, Y., Kenigsberg, J., Kruk, J., Schotola, C., Shinkarev, S. et al. (2006) Thyroid cancer among Ukrainians and Belarusians who were children or adolescents at the time of the Chernobyl accident. J. Radiol. Prot., 26, 51-67.
10. Likhtarev, I., Bouville, A., Kovgan, L., Luckyanov, N., Voilleque, P. and Chepurny, M. (2006) Questionnaire- and measurement-based individual thyroid doses in Ukraine resulting from the Chornobyl nuclear reactor accident. Radiat. Res., 166, 271-286.
11. Gudmundsson, J., Sulem, P., Gudbjartsson, D.F., Jonasson, J.G., Sigurdsson, A., Bergthorsson, J.T., He, H., Blondal, T., Geller, F., Jakobsdottir, M. et al. (2009) Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet., 41, 460-464.
12. Landa, I., Ruiz-Llorente, S., Montero-Conde, C., Inglada-Perez, L., Schiavi, F., Leskela, S., Pita, G., Milne, R., Maravall, J., Ramos, I. et al. (2009) The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet., 5, e1000637.
13. UNSCEAR (1994) In. United Nations Scientific Committee on the Effects of Atomic Radiation, 1994 Report to the General Assembly, New York.
14. Zannini, M., Avantaggiato, V., Biffali, E., Arnone, M.I., Sato, K., Pischetola, M., Taylor, B.A., Phillips, S.J., Simeone, A. and Di Lauro, R. (1997) TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J., 16, 3185-3197.
15. Chadwick, B.P., Obermayr, F. and Frischauf, A.M. (1997) FKHL15, a new human member of the forkhead gene family located on chromosome 9q22. Genomics, 41, 390-396.
16. Williams, E.D., Abrosimov, A., Bogdanova, T., Demidchik, E.P., Ito, M., LiVolsi, V., Lushnikov, E., Rosai, J., Sidorov, Y., Tronko, M.D. et al. (2004) Thyroid carcinoma after Chernobyl latent period, morphology and aggressiveness. Br. J. Cancer, 90, 2219-2224.
17. Rogounovitch, T.I., Saenko, V.A., Ashizawa, K., Sedliarou, I.A., Namba, H., Abrosimov, A.Y., Lushnikov, E.F., Roumiantsev, P.O., Konova, M.V., Petoukhova, N.S. et al. (2006) TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol. Rep., 15, 949-956.
18. Akulevich, N.M., Saenko, V.A., Rogounovitch, T.I., Drozd, V.M., Lushnikov, E.F., Ivanov, V.K., Mitsutake, N., Kominami, R. and Yamashita, S. (2009) Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr. Relat. Cancer, 16, 491-503.
19. Stephens, L.A., Powell, N.G., Grubb, J., Jeremiah, S.J., Bethel, J.A., Demidchik, E.P., Bogdanova, T.I., Tronko, M.D. and Thomas, G.A. (2005) Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma. Thyroid, 15, 100-104.
20. Lonn, S., Bhatti, P., Alexander, B.H., Pineda, M.A., Doody, M.M., Struewing, J.P. and Sigurdson, A.J. (2007) Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologists. Cancer Epidemiol. Biomarkers Prev., 16, 174-177.
21. Sigurdson, A.J., Land, C.E., Bhatti, P., Pineda, M., Brenner, A., Carr, Z., Gusev, B.I., Zhumadilov, Z., Simon, S.L., Bouville, A. et al. (2009) Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat. Res., 171, 77-88.
22. Kruk, J.E., Prohl, G. and Kenigsberg, J.I. (2004) A radioecological model for thyroid dose reconstruction of the Belarus population following the Chernobyl accident. Radiat. Environ. Biophys., 43, 101-110.
23. Bouville, A., Likhtarev, I.A., Kovgan, L.N., Minenko, V.F., Shinkarev, S.M. and Drozdovitch, V.V. (2007) Radiation dosimetry for highly contaminated Belarusian, Russian and Ukrainian populations, and for less contaminated populations in Europe. Health Phys., 93, 487-501.
24. Heath, S.C., Gut, I.G., Brennan, P., McKay, J.D., Bencko, V., Fabianova, E., Foretova, L., Georges, M., Janout, V., Kabesch, M. et al. (2008) Investigation of the fine structure of European populations with applications to disease association studies. Eur. J. Hum. Genet., 16, 1413-1429.
25. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
26. Price, A.L., Patterson, N.J., Plenge, R.M., Weinblatt, M.E., Shadick, N.A. and Reich, D. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet., 38, 904-909.
27. Yamada, R. and Okada, Y. (2009) An optimal dose-effect mode trend test for SNP genotype tables. Genet. Epidemiol., 33, 114-127.
28. Devlin, B. and Roeder, K. (1999) Genomic control for association studies. Biometrics, 55, 997-1004.
29. Woolson, R.F. and Bean, J.A. (1982) Mantel-Haenszel statistics and direct standardization. Stat. Med., 1, 37-39.
30. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.